| SHORT COMMUNICATION |
|
| Year : 2023 | Volume
: 55
| Issue : 1 | Page : 53-58 |
Peptides and peptidomimetics as a therapeutic candidate for the treatment of COVID-19: A brief review
J Kumaravel, Harvinder Singh, Sukhmeet Kaur, Ajay Prakash, Bikash Medhi
Department of Pharmacology, PGIMER, Chandigarh, India
Correspondence Address:
Bikash Medhi
Department of Pharmacology, PGIMER, Chandigarh
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/ijp.ijp_700_22
Novel SARS-CoV-2 (COVID-19) is affecting worldwide as declared pandemic by the WHO. Various repositioning and novel therapeutic agents are being evaluated under different clinical setups; however, there is no promising therapeutic agent reported to date. Small molecules like peptides have their popularity as their specificity, delivery, and synthesizability as promising therapeutic agents. In this study, we have reviewed the published literature describing peptide designing, in silico binding mode, antiviral activity, preventive measures, and in vivo assessments. Here, we reported all the results which are promising against SARS-CoV-2 as therapeutic and preventive (vaccine candidates), and their status in the drug development process.
[FULL TEXT] [PDF]*
|
